These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

958 related articles for article (PubMed ID: 26992033)

  • 1. Phenotypic switching of vascular smooth muscle cells in the 'normal region' of aorta from atherosclerosis patients is regulated by miR-145.
    Zhang YN; Xie BD; Sun L; Chen W; Jiang SL; Liu W; Bian F; Tian H; Li RK
    J Cell Mol Med; 2016 Jun; 20(6):1049-61. PubMed ID: 26992033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNA let-7g suppresses PDGF-induced conversion of vascular smooth muscle cell into the synthetic phenotype.
    Wang TM; Chen KC; Hsu PY; Lin HF; Wang YS; Chen CY; Liao YC; Juo SH
    J Cell Mol Med; 2017 Dec; 21(12):3592-3601. PubMed ID: 28699690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-31 controls phenotypic modulation of human vascular smooth muscle cells by regulating its target gene cellular repressor of E1A-stimulated genes.
    Wang J; Yan CH; Li Y; Xu K; Tian XX; Peng CF; Tao J; Sun MY; Han YL
    Exp Cell Res; 2013 May; 319(8):1165-75. PubMed ID: 23518389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-124 controls human vascular smooth muscle cell phenotypic switch via Sp1.
    Tang Y; Yu S; Liu Y; Zhang J; Han L; Xu Z
    Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H641-H649. PubMed ID: 28667053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of miR-23b induces phenotypic switching of vascular smooth muscle cells in vitro and in vivo.
    Iaconetti C; De Rosa S; Polimeni A; Sorrentino S; Gareri C; Carino A; Sabatino J; Colangelo M; Curcio A; Indolfi C
    Cardiovasc Res; 2015 Sep; 107(4):522-33. PubMed ID: 25994172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation.
    Cheng Y; Liu X; Yang J; Lin Y; Xu DZ; Lu Q; Deitch EA; Huo Y; Delphin ES; Zhang C
    Circ Res; 2009 Jul; 105(2):158-66. PubMed ID: 19542014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-145 micelles mitigate atherosclerosis by modulating vascular smooth muscle cell phenotype.
    Chin DD; Poon C; Wang J; Joo J; Ong V; Jiang Z; Cheng K; Plotkin A; Magee GA; Chung EJ
    Biomaterials; 2021 Jun; 273():120810. PubMed ID: 33892346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-146b-3p regulates the dysfunction of vascular smooth muscle cells via repressing phosphoinositide-3 kinase catalytic subunit gamma.
    Zhuang X; Gao F; Shi L; Liu W; Wang W; He X; Gao Y
    Bioengineered; 2021 Dec; 12(1):2627-2638. PubMed ID: 34115567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micro-RNA-338-3p Promotes the Development of Atherosclerosis by Targeting Desmin and Promoting Proliferation.
    Yan S; Chen J; Zhang T; Zhou J; Wang G; Li Y
    Mol Biotechnol; 2021 Sep; 63(9):840-848. PubMed ID: 34100182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-145 mediated the role of aspirin in resisting VSMCs proliferation and anti-inflammation through CD40.
    Guo X; Yu L; Chen M; Wu T; Peng X; Guo R; Zhang B
    J Transl Med; 2016 Jul; 14(1):211. PubMed ID: 27412561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TUG1 knockdown ameliorates atherosclerosis via up-regulating the expression of miR-133a target gene FGF1.
    Zhang L; Cheng H; Yue Y; Li S; Zhang D; He R
    Cardiovasc Pathol; 2018; 33():6-15. PubMed ID: 29268138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-124-3p inhibits collagen synthesis in atherosclerotic plaques by targeting prolyl 4-hydroxylase subunit alpha-1 (P4HA1) in vascular smooth muscle cells.
    Chen W; Yu F; Di M; Li M; Chen Y; Zhang Y; Liu X; Huang X; Zhang M
    Atherosclerosis; 2018 Oct; 277():98-107. PubMed ID: 30193190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H19 knockdown suppresses proliferation and induces apoptosis by regulating miR-148b/WNT/β-catenin in ox-LDL -stimulated vascular smooth muscle cells.
    Zhang L; Cheng H; Yue Y; Li S; Zhang D; He R
    J Biomed Sci; 2018 Feb; 25(1):11. PubMed ID: 29415742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intercellular transfer of miR-126-3p by endothelial microparticles reduces vascular smooth muscle cell proliferation and limits neointima formation by inhibiting LRP6.
    Jansen F; Stumpf T; Proebsting S; Franklin BS; Wenzel D; Pfeifer P; Flender A; Schmitz T; Yang X; Fleischmann BK; Nickenig G; Werner N
    J Mol Cell Cardiol; 2017 Mar; 104():43-52. PubMed ID: 28143713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of miR-202 in varicose veins modulates phenotypic transition of vascular smooth muscle cells by targeting proliferator-activated receptor-γ coactivator-1α.
    Huang X; Liu Z; Shen L; Jin Y; Xu G; Zhang Z; Fang C; Guan W; Liu C
    J Cell Biochem; 2019 Jun; 120(6):10031-10042. PubMed ID: 30556158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardin/microRNA-30a/Beclin1 signaling controls the phenotypic modulation of vascular smooth muscle cells by regulating autophagy.
    Shi D; Ding J; Xie S; Huang L; Zhang H; Chen X; Ren X; Zhou S; He H; Ma W; Zhang T; Wang N
    Cell Death Dis; 2022 Feb; 13(2):121. PubMed ID: 35136037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of Herp alleviates hyperhomocysteinemia mediated atherosclerosis through the inhibition of vascular smooth muscle cell phenotype switching.
    Lin H; Ni T; Zhang J; Meng L; Gao F; Pan S; Luo H; Xu F; Ru G; Chi J; Guo H
    Int J Cardiol; 2018 Oct; 269():242-249. PubMed ID: 30017525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-448 promotes vascular smooth muscle cell proliferation and migration in through directly targeting MEF2C.
    Zhang R; Sui L; Hong X; Yang M; Li W
    Environ Sci Pollut Res Int; 2017 Oct; 24(28):22294-22300. PubMed ID: 28799067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flank sequences of miR-145/143 and their aberrant expression in vascular disease: mechanism and therapeutic application.
    Liu X; Cheng Y; Yang J; Qin S; Chen X; Tang X; Zhou X; Krall TJ; Zhang C
    J Am Heart Assoc; 2013 Oct; 2(6):e000407. PubMed ID: 24166492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamine switches vascular smooth muscle cells to synthetic phenotype through inhibiting miR-143 expression and upregulating THY1 expression.
    Zhang CY; Hu YC; Zhang Y; Ma WD; Song YF; Quan XH; Guo X; Wang CX
    Life Sci; 2021 Jul; 277():119365. PubMed ID: 33741416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.